Zu "405169-16-6" wurden 3 Artikel gefunden!

Für die Filterung wurden keine Ergebnisse gefunden!
Dovitinib, Free Base (4-Amino-5-fluoro-3-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-qui
Dovitinib, Free Base...

Artikelnummer: D9060.10

Dovitinib is a small-molecule multi-targeted receptor tyrosine kinase inhibitor. Dovitinib inhibited Ba/F3 cells transformed to IL3 independence by ZNF198-FGFR1 or BCR-FGFR1 with IC50 values of 150nM and 90nM, respectively. The phosphorylation of each fusion gene, ERK, and STAT5 was inhibited as well at the same...
CAS 405169-16-6
MW: 392.43
261,00 €
Bewerten
Dovitinib
Dovitinib

Artikelnummer: Cay15220-10

Dovitinib is a multi-kinase inhibitor. It inhibits the receptor tyrosine kinases FLT3, CSF1R, and c-Kit (IC50s = 1, 36, and 2 nM, respectively), as well as FGFR1, FGFR3, VEGFR1-3, PDFGRalpha, and PDGFRbeta (IC50s = 8, 9, 10, 13, 8, 27, and 210 nM, respectively). Dovitinib inhibits proliferation of human multiple...
Schlagworte: CHIR-258, TKI-258, 4-amino-5-fluoro-3-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone
Anwendung: PDGFRB / VEGFR2 / FGFR1 inhibitor
CAS 405169-16-6
MW: 392.4 D
ab 181,00 €
Bewerten
Dovitinib
Dovitinib

Artikelnummer: TGM-T6289-100mg

Description: Dovitinib (CHIR-258) (TKI258, CHIR258) is a multitargeted RTK inhibitor, mostly for class III (FLT3/c-Kit, IC50: 1/2 nM), also effective to class IV (FGFR1/3) and class V (VEGFR1-4) RTKs (IC50: 8-13 nM), less potent to EGFR, InsR, EphA2, c-Met, IGF-1R, Tie2, and HER2. Target: VEGFR, FGFR, c-Kit,...
Schlagworte: CHIR-258, TKI258
Anwendung: PDGFRB / VEGFR2 / FGFR1 inhibitor
CAS 405169-16-6
MW: 392.43 D
ab 38,00 €
Bewerten